Global Recombinant Human Somatropin for Injection Supply, Demand and Key Producers, 2023-2029
The global Recombinant Human Somatropin for Injection market size is expected to reach $ 3151.1 million by 2029, rising at a market growth of 3.4% CAGR during the forecast period (2023-2029).
Recombinant Human Somatropin for Injection is a widely used biopharmaceutical in the medical field, primarily employed in the treatment of growth hormone deficiency, short stature, muscle wasting, and related conditions. The market size is substantial, driven by ongoing concerns related to endocrine and growth issues in both children and adults. Sales of the product have steadily increased over the years and are expected to continue to show potential in the future, particularly with the introduction of new therapeutic applications and improved delivery methods, such as enhanced injection devices. Furthermore, as medical science and technology continue to advance, recombinant human somatropin may find applications in a broader spectrum of health fields, creating more opportunities for its future development.
Recombinant Human Somatropin, commonly known as somatropin or human growth hormone (hGH), is a synthetic form of the growth hormone produced naturally in the human body. Somatropin is created using recombinant DNA technology, and it is structurally identical to the growth hormone secreted by the pituitary gland. It is used for various medical and non-medical purposes.
This report studies the global Recombinant Human Somatropin for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human Somatropin for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Somatropin for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human Somatropin for Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Human Somatropin for Injection total production value, 2018-2029, (USD Million)
Global Recombinant Human Somatropin for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Somatropin for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Somatropin for Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Somatropin for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Somatropin for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Somatropin for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Human Somatropin for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck, Roche, Changchun GeneScience Pharmaceutical, Anhui Anke Biotechnology and Shanghai United Cell Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Somatropin for Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human Somatropin for Injection Market, By Region:
1. How big is the global Recombinant Human Somatropin for Injection market?
2. What is the demand of the global Recombinant Human Somatropin for Injection market?
3. What is the year over year growth of the global Recombinant Human Somatropin for Injection market?
4. What is the production and production value of the global Recombinant Human Somatropin for Injection market?
5. Who are the key producers in the global Recombinant Human Somatropin for Injection market?
Recombinant Human Somatropin for Injection is a widely used biopharmaceutical in the medical field, primarily employed in the treatment of growth hormone deficiency, short stature, muscle wasting, and related conditions. The market size is substantial, driven by ongoing concerns related to endocrine and growth issues in both children and adults. Sales of the product have steadily increased over the years and are expected to continue to show potential in the future, particularly with the introduction of new therapeutic applications and improved delivery methods, such as enhanced injection devices. Furthermore, as medical science and technology continue to advance, recombinant human somatropin may find applications in a broader spectrum of health fields, creating more opportunities for its future development.
Recombinant Human Somatropin, commonly known as somatropin or human growth hormone (hGH), is a synthetic form of the growth hormone produced naturally in the human body. Somatropin is created using recombinant DNA technology, and it is structurally identical to the growth hormone secreted by the pituitary gland. It is used for various medical and non-medical purposes.
This report studies the global Recombinant Human Somatropin for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Human Somatropin for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Human Somatropin for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Human Somatropin for Injection total production and demand, 2018-2029, (K Units)
Global Recombinant Human Somatropin for Injection total production value, 2018-2029, (USD Million)
Global Recombinant Human Somatropin for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Somatropin for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Human Somatropin for Injection domestic production, consumption, key domestic manufacturers and share
Global Recombinant Human Somatropin for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Human Somatropin for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Human Somatropin for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Recombinant Human Somatropin for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck, Roche, Changchun GeneScience Pharmaceutical, Anhui Anke Biotechnology and Shanghai United Cell Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Human Somatropin for Injection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Human Somatropin for Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Powder Injection
- Aqueous Injection
- Hospital
- Clinic
- Others
- Novo Nordisk
- LG Chem
- Pfizer
- Eli lilly
- Merck
- Roche
- Changchun GeneScience Pharmaceutical
- Anhui Anke Biotechnology
- Shanghai United Cell Biotechnology
- Zhongshan Sinobioway Hygene Biomedicine
1. How big is the global Recombinant Human Somatropin for Injection market?
2. What is the demand of the global Recombinant Human Somatropin for Injection market?
3. What is the year over year growth of the global Recombinant Human Somatropin for Injection market?
4. What is the production and production value of the global Recombinant Human Somatropin for Injection market?
5. Who are the key producers in the global Recombinant Human Somatropin for Injection market?
1 SUPPLY SUMMARY
1.1 Recombinant Human Somatropin for Injection Introduction
1.2 World Recombinant Human Somatropin for Injection Supply & Forecast
1.2.1 World Recombinant Human Somatropin for Injection Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human Somatropin for Injection Production (2018-2029)
1.2.3 World Recombinant Human Somatropin for Injection Pricing Trends (2018-2029)
1.3 World Recombinant Human Somatropin for Injection Production by Region (Based on Production Site)
1.3.1 World Recombinant Human Somatropin for Injection Production Value by Region (2018-2029)
1.3.2 World Recombinant Human Somatropin for Injection Production by Region (2018-2029)
1.3.3 World Recombinant Human Somatropin for Injection Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human Somatropin for Injection Production (2018-2029)
1.3.5 Europe Recombinant Human Somatropin for Injection Production (2018-2029)
1.3.6 China Recombinant Human Somatropin for Injection Production (2018-2029)
1.3.7 Japan Recombinant Human Somatropin for Injection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human Somatropin for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human Somatropin for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Human Somatropin for Injection Demand (2018-2029)
2.2 World Recombinant Human Somatropin for Injection Consumption by Region
2.2.1 World Recombinant Human Somatropin for Injection Consumption by Region (2018-2023)
2.2.2 World Recombinant Human Somatropin for Injection Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.4 China Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.5 Europe Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.6 Japan Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.7 South Korea Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.8 ASEAN Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.9 India Recombinant Human Somatropin for Injection Consumption (2018-2029)
3 WORLD RECOMBINANT HUMAN SOMATROPIN FOR INJECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Human Somatropin for Injection Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human Somatropin for Injection Production by Manufacturer (2018-2023)
3.3 World Recombinant Human Somatropin for Injection Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human Somatropin for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human Somatropin for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Somatropin for Injection in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Somatropin for Injection in 2022
3.6 Recombinant Human Somatropin for Injection Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human Somatropin for Injection Market: Region Footprint
3.6.2 Recombinant Human Somatropin for Injection Market: Company Product Type Footprint
3.6.3 Recombinant Human Somatropin for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Human Somatropin for Injection Production Value Comparison
4.1.1 United States VS China: Recombinant Human Somatropin for Injection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human Somatropin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human Somatropin for Injection Production Comparison
4.2.1 United States VS China: Recombinant Human Somatropin for Injection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human Somatropin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human Somatropin for Injection Consumption Comparison
4.3.1 United States VS China: Recombinant Human Somatropin for Injection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human Somatropin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human Somatropin for Injection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human Somatropin for Injection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023)
4.5 China Based Recombinant Human Somatropin for Injection Manufacturers and Market Share
4.5.1 China Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human Somatropin for Injection Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023)
4.6 Rest of World Based Recombinant Human Somatropin for Injection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Human Somatropin for Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Powder Injection
5.2.2 Aqueous Injection
5.3 Market Segment by Type
5.3.1 World Recombinant Human Somatropin for Injection Production by Type (2018-2029)
5.3.2 World Recombinant Human Somatropin for Injection Production Value by Type (2018-2029)
5.3.3 World Recombinant Human Somatropin for Injection Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Human Somatropin for Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Human Somatropin for Injection Production by Application (2018-2029)
6.3.2 World Recombinant Human Somatropin for Injection Production Value by Application (2018-2029)
6.3.3 World Recombinant Human Somatropin for Injection Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk Recombinant Human Somatropin for Injection Product and Services
7.1.4 Novo Nordisk Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 LG Chem
7.2.1 LG Chem Details
7.2.2 LG Chem Major Business
7.2.3 LG Chem Recombinant Human Somatropin for Injection Product and Services
7.2.4 LG Chem Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 LG Chem Recent Developments/Updates
7.2.6 LG Chem Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Recombinant Human Somatropin for Injection Product and Services
7.3.4 Pfizer Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Eli lilly
7.4.1 Eli lilly Details
7.4.2 Eli lilly Major Business
7.4.3 Eli lilly Recombinant Human Somatropin for Injection Product and Services
7.4.4 Eli lilly Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Eli lilly Recent Developments/Updates
7.4.6 Eli lilly Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Recombinant Human Somatropin for Injection Product and Services
7.5.4 Merck Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche Recombinant Human Somatropin for Injection Product and Services
7.6.4 Roche Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
7.7 Changchun GeneScience Pharmaceutical
7.7.1 Changchun GeneScience Pharmaceutical Details
7.7.2 Changchun GeneScience Pharmaceutical Major Business
7.7.3 Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Product and Services
7.7.4 Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
7.7.6 Changchun GeneScience Pharmaceutical Competitive Strengths & Weaknesses
7.8 Anhui Anke Biotechnology
7.8.1 Anhui Anke Biotechnology Details
7.8.2 Anhui Anke Biotechnology Major Business
7.8.3 Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Product and Services
7.8.4 Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Anhui Anke Biotechnology Recent Developments/Updates
7.8.6 Anhui Anke Biotechnology Competitive Strengths & Weaknesses
7.9 Shanghai United Cell Biotechnology
7.9.1 Shanghai United Cell Biotechnology Details
7.9.2 Shanghai United Cell Biotechnology Major Business
7.9.3 Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Product and Services
7.9.4 Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shanghai United Cell Biotechnology Recent Developments/Updates
7.9.6 Shanghai United Cell Biotechnology Competitive Strengths & Weaknesses
7.10 Zhongshan Sinobioway Hygene Biomedicine
7.10.1 Zhongshan Sinobioway Hygene Biomedicine Details
7.10.2 Zhongshan Sinobioway Hygene Biomedicine Major Business
7.10.3 Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Product and Services
7.10.4 Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments/Updates
7.10.6 Zhongshan Sinobioway Hygene Biomedicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Human Somatropin for Injection Industry Chain
8.2 Recombinant Human Somatropin for Injection Upstream Analysis
8.2.1 Recombinant Human Somatropin for Injection Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human Somatropin for Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human Somatropin for Injection Production Mode
8.6 Recombinant Human Somatropin for Injection Procurement Model
8.7 Recombinant Human Somatropin for Injection Industry Sales Model and Sales Channels
8.7.1 Recombinant Human Somatropin for Injection Sales Model
8.7.2 Recombinant Human Somatropin for Injection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Recombinant Human Somatropin for Injection Introduction
1.2 World Recombinant Human Somatropin for Injection Supply & Forecast
1.2.1 World Recombinant Human Somatropin for Injection Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Human Somatropin for Injection Production (2018-2029)
1.2.3 World Recombinant Human Somatropin for Injection Pricing Trends (2018-2029)
1.3 World Recombinant Human Somatropin for Injection Production by Region (Based on Production Site)
1.3.1 World Recombinant Human Somatropin for Injection Production Value by Region (2018-2029)
1.3.2 World Recombinant Human Somatropin for Injection Production by Region (2018-2029)
1.3.3 World Recombinant Human Somatropin for Injection Average Price by Region (2018-2029)
1.3.4 North America Recombinant Human Somatropin for Injection Production (2018-2029)
1.3.5 Europe Recombinant Human Somatropin for Injection Production (2018-2029)
1.3.6 China Recombinant Human Somatropin for Injection Production (2018-2029)
1.3.7 Japan Recombinant Human Somatropin for Injection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Human Somatropin for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Human Somatropin for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Human Somatropin for Injection Demand (2018-2029)
2.2 World Recombinant Human Somatropin for Injection Consumption by Region
2.2.1 World Recombinant Human Somatropin for Injection Consumption by Region (2018-2023)
2.2.2 World Recombinant Human Somatropin for Injection Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.4 China Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.5 Europe Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.6 Japan Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.7 South Korea Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.8 ASEAN Recombinant Human Somatropin for Injection Consumption (2018-2029)
2.9 India Recombinant Human Somatropin for Injection Consumption (2018-2029)
3 WORLD RECOMBINANT HUMAN SOMATROPIN FOR INJECTION MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Human Somatropin for Injection Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Human Somatropin for Injection Production by Manufacturer (2018-2023)
3.3 World Recombinant Human Somatropin for Injection Average Price by Manufacturer (2018-2023)
3.4 Recombinant Human Somatropin for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Human Somatropin for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Human Somatropin for Injection in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Human Somatropin for Injection in 2022
3.6 Recombinant Human Somatropin for Injection Market: Overall Company Footprint Analysis
3.6.1 Recombinant Human Somatropin for Injection Market: Region Footprint
3.6.2 Recombinant Human Somatropin for Injection Market: Company Product Type Footprint
3.6.3 Recombinant Human Somatropin for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Human Somatropin for Injection Production Value Comparison
4.1.1 United States VS China: Recombinant Human Somatropin for Injection Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Human Somatropin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Human Somatropin for Injection Production Comparison
4.2.1 United States VS China: Recombinant Human Somatropin for Injection Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Human Somatropin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Human Somatropin for Injection Consumption Comparison
4.3.1 United States VS China: Recombinant Human Somatropin for Injection Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Human Somatropin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Human Somatropin for Injection Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Human Somatropin for Injection Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023)
4.5 China Based Recombinant Human Somatropin for Injection Manufacturers and Market Share
4.5.1 China Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Human Somatropin for Injection Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023)
4.6 Rest of World Based Recombinant Human Somatropin for Injection Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Human Somatropin for Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Powder Injection
5.2.2 Aqueous Injection
5.3 Market Segment by Type
5.3.1 World Recombinant Human Somatropin for Injection Production by Type (2018-2029)
5.3.2 World Recombinant Human Somatropin for Injection Production Value by Type (2018-2029)
5.3.3 World Recombinant Human Somatropin for Injection Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Human Somatropin for Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Human Somatropin for Injection Production by Application (2018-2029)
6.3.2 World Recombinant Human Somatropin for Injection Production Value by Application (2018-2029)
6.3.3 World Recombinant Human Somatropin for Injection Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk Recombinant Human Somatropin for Injection Product and Services
7.1.4 Novo Nordisk Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 LG Chem
7.2.1 LG Chem Details
7.2.2 LG Chem Major Business
7.2.3 LG Chem Recombinant Human Somatropin for Injection Product and Services
7.2.4 LG Chem Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 LG Chem Recent Developments/Updates
7.2.6 LG Chem Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Recombinant Human Somatropin for Injection Product and Services
7.3.4 Pfizer Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Eli lilly
7.4.1 Eli lilly Details
7.4.2 Eli lilly Major Business
7.4.3 Eli lilly Recombinant Human Somatropin for Injection Product and Services
7.4.4 Eli lilly Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Eli lilly Recent Developments/Updates
7.4.6 Eli lilly Competitive Strengths & Weaknesses
7.5 Merck
7.5.1 Merck Details
7.5.2 Merck Major Business
7.5.3 Merck Recombinant Human Somatropin for Injection Product and Services
7.5.4 Merck Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Merck Recent Developments/Updates
7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche Recombinant Human Somatropin for Injection Product and Services
7.6.4 Roche Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
7.7 Changchun GeneScience Pharmaceutical
7.7.1 Changchun GeneScience Pharmaceutical Details
7.7.2 Changchun GeneScience Pharmaceutical Major Business
7.7.3 Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Product and Services
7.7.4 Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
7.7.6 Changchun GeneScience Pharmaceutical Competitive Strengths & Weaknesses
7.8 Anhui Anke Biotechnology
7.8.1 Anhui Anke Biotechnology Details
7.8.2 Anhui Anke Biotechnology Major Business
7.8.3 Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Product and Services
7.8.4 Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Anhui Anke Biotechnology Recent Developments/Updates
7.8.6 Anhui Anke Biotechnology Competitive Strengths & Weaknesses
7.9 Shanghai United Cell Biotechnology
7.9.1 Shanghai United Cell Biotechnology Details
7.9.2 Shanghai United Cell Biotechnology Major Business
7.9.3 Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Product and Services
7.9.4 Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Shanghai United Cell Biotechnology Recent Developments/Updates
7.9.6 Shanghai United Cell Biotechnology Competitive Strengths & Weaknesses
7.10 Zhongshan Sinobioway Hygene Biomedicine
7.10.1 Zhongshan Sinobioway Hygene Biomedicine Details
7.10.2 Zhongshan Sinobioway Hygene Biomedicine Major Business
7.10.3 Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Product and Services
7.10.4 Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Zhongshan Sinobioway Hygene Biomedicine Recent Developments/Updates
7.10.6 Zhongshan Sinobioway Hygene Biomedicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Human Somatropin for Injection Industry Chain
8.2 Recombinant Human Somatropin for Injection Upstream Analysis
8.2.1 Recombinant Human Somatropin for Injection Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Human Somatropin for Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Human Somatropin for Injection Production Mode
8.6 Recombinant Human Somatropin for Injection Procurement Model
8.7 Recombinant Human Somatropin for Injection Industry Sales Model and Sales Channels
8.7.1 Recombinant Human Somatropin for Injection Sales Model
8.7.2 Recombinant Human Somatropin for Injection Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Human Somatropin for Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human Somatropin for Injection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human Somatropin for Injection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human Somatropin for Injection Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human Somatropin for Injection Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human Somatropin for Injection Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human Somatropin for Injection Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human Somatropin for Injection Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human Somatropin for Injection Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human Somatropin for Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human Somatropin for Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human Somatropin for Injection Major Market Trends
Table 13. World Recombinant Human Somatropin for Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human Somatropin for Injection Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human Somatropin for Injection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human Somatropin for Injection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human Somatropin for Injection Producers in 2022
Table 18. World Recombinant Human Somatropin for Injection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human Somatropin for Injection Producers in 2022
Table 20. World Recombinant Human Somatropin for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human Somatropin for Injection Company Evaluation Quadrant
Table 22. World Recombinant Human Somatropin for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human Somatropin for Injection Production Site of Key Manufacturer
Table 24. Recombinant Human Somatropin for Injection Market: Company Product Type Footprint
Table 25. Recombinant Human Somatropin for Injection Market: Company Product Application Footprint
Table 26. Recombinant Human Somatropin for Injection Competitive Factors
Table 27. Recombinant Human Somatropin for Injection New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human Somatropin for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human Somatropin for Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human Somatropin for Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human Somatropin for Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share (2018-2023)
Table 37. China Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human Somatropin for Injection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human Somatropin for Injection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share (2018-2023)
Table 47. World Recombinant Human Somatropin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human Somatropin for Injection Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human Somatropin for Injection Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human Somatropin for Injection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human Somatropin for Injection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human Somatropin for Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human Somatropin for Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human Somatropin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human Somatropin for Injection Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human Somatropin for Injection Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human Somatropin for Injection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human Somatropin for Injection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human Somatropin for Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human Somatropin for Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk Recombinant Human Somatropin for Injection Product and Services
Table 64. Novo Nordisk Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. LG Chem Basic Information, Manufacturing Base and Competitors
Table 68. LG Chem Major Business
Table 69. LG Chem Recombinant Human Somatropin for Injection Product and Services
Table 70. LG Chem Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. LG Chem Recent Developments/Updates
Table 72. LG Chem Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Recombinant Human Somatropin for Injection Product and Services
Table 76. Pfizer Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Eli lilly Basic Information, Manufacturing Base and Competitors
Table 80. Eli lilly Major Business
Table 81. Eli lilly Recombinant Human Somatropin for Injection Product and Services
Table 82. Eli lilly Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Eli lilly Recent Developments/Updates
Table 84. Eli lilly Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Recombinant Human Somatropin for Injection Product and Services
Table 88. Merck Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Roche Basic Information, Manufacturing Base and Competitors
Table 92. Roche Major Business
Table 93. Roche Recombinant Human Somatropin for Injection Product and Services
Table 94. Roche Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Recent Developments/Updates
Table 96. Roche Competitive Strengths & Weaknesses
Table 97. Changchun GeneScience Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Changchun GeneScience Pharmaceutical Major Business
Table 99. Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Product and Services
Table 100. Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Changchun GeneScience Pharmaceutical Recent Developments/Updates
Table 102. Changchun GeneScience Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Anhui Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 104. Anhui Anke Biotechnology Major Business
Table 105. Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Product and Services
Table 106. Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Anhui Anke Biotechnology Recent Developments/Updates
Table 108. Anhui Anke Biotechnology Competitive Strengths & Weaknesses
Table 109. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 110. Shanghai United Cell Biotechnology Major Business
Table 111. Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Product and Services
Table 112. Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 114. Zhongshan Sinobioway Hygene Biomedicine Basic Information, Manufacturing Base and Competitors
Table 115. Zhongshan Sinobioway Hygene Biomedicine Major Business
Table 116. Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Product and Services
Table 117. Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Recombinant Human Somatropin for Injection Upstream (Raw Materials)
Table 119. Recombinant Human Somatropin for Injection Typical Customers
Table 120. Recombinant Human Somatropin for Injection Typical Distributors
LIST OF FIGURE
Figure 1. Recombinant Human Somatropin for Injection Picture
Figure 2. World Recombinant Human Somatropin for Injection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human Somatropin for Injection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human Somatropin for Injection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human Somatropin for Injection Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human Somatropin for Injection Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 12. Recombinant Human Somatropin for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human Somatropin for Injection Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human Somatropin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Somatropin for Injection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Somatropin for Injection Markets in 2022
Figure 26. United States VS China: Recombinant Human Somatropin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human Somatropin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human Somatropin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share 2022
Figure 32. World Recombinant Human Somatropin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human Somatropin for Injection Production Value Market Share by Type in 2022
Figure 34. Powder Injection
Figure 35. Aqueous Injection
Figure 36. World Recombinant Human Somatropin for Injection Production Market Share by Type (2018-2029)
Figure 37. World Recombinant Human Somatropin for Injection Production Value Market Share by Type (2018-2029)
Figure 38. World Recombinant Human Somatropin for Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Recombinant Human Somatropin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Recombinant Human Somatropin for Injection Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Recombinant Human Somatropin for Injection Production Market Share by Application (2018-2029)
Figure 45. World Recombinant Human Somatropin for Injection Production Value Market Share by Application (2018-2029)
Figure 46. World Recombinant Human Somatropin for Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Recombinant Human Somatropin for Injection Industry Chain
Figure 48. Recombinant Human Somatropin for Injection Procurement Model
Figure 49. Recombinant Human Somatropin for Injection Sales Model
Figure 50. Recombinant Human Somatropin for Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Recombinant Human Somatropin for Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Human Somatropin for Injection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Human Somatropin for Injection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Human Somatropin for Injection Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Human Somatropin for Injection Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Human Somatropin for Injection Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Human Somatropin for Injection Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Human Somatropin for Injection Production Market Share by Region (2018-2023)
Table 9. World Recombinant Human Somatropin for Injection Production Market Share by Region (2024-2029)
Table 10. World Recombinant Human Somatropin for Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Human Somatropin for Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Human Somatropin for Injection Major Market Trends
Table 13. World Recombinant Human Somatropin for Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Human Somatropin for Injection Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Human Somatropin for Injection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Human Somatropin for Injection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Human Somatropin for Injection Producers in 2022
Table 18. World Recombinant Human Somatropin for Injection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Human Somatropin for Injection Producers in 2022
Table 20. World Recombinant Human Somatropin for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Human Somatropin for Injection Company Evaluation Quadrant
Table 22. World Recombinant Human Somatropin for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Human Somatropin for Injection Production Site of Key Manufacturer
Table 24. Recombinant Human Somatropin for Injection Market: Company Product Type Footprint
Table 25. Recombinant Human Somatropin for Injection Market: Company Product Application Footprint
Table 26. Recombinant Human Somatropin for Injection Competitive Factors
Table 27. Recombinant Human Somatropin for Injection New Entrant and Capacity Expansion Plans
Table 28. Recombinant Human Somatropin for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Human Somatropin for Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Human Somatropin for Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Human Somatropin for Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share (2018-2023)
Table 37. China Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Human Somatropin for Injection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Human Somatropin for Injection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Human Somatropin for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share (2018-2023)
Table 47. World Recombinant Human Somatropin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Human Somatropin for Injection Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Human Somatropin for Injection Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Human Somatropin for Injection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Human Somatropin for Injection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Human Somatropin for Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Human Somatropin for Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Human Somatropin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Human Somatropin for Injection Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Human Somatropin for Injection Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Human Somatropin for Injection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Human Somatropin for Injection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Human Somatropin for Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Human Somatropin for Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk Recombinant Human Somatropin for Injection Product and Services
Table 64. Novo Nordisk Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. LG Chem Basic Information, Manufacturing Base and Competitors
Table 68. LG Chem Major Business
Table 69. LG Chem Recombinant Human Somatropin for Injection Product and Services
Table 70. LG Chem Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. LG Chem Recent Developments/Updates
Table 72. LG Chem Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Recombinant Human Somatropin for Injection Product and Services
Table 76. Pfizer Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Eli lilly Basic Information, Manufacturing Base and Competitors
Table 80. Eli lilly Major Business
Table 81. Eli lilly Recombinant Human Somatropin for Injection Product and Services
Table 82. Eli lilly Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Eli lilly Recent Developments/Updates
Table 84. Eli lilly Competitive Strengths & Weaknesses
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Major Business
Table 87. Merck Recombinant Human Somatropin for Injection Product and Services
Table 88. Merck Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Merck Recent Developments/Updates
Table 90. Merck Competitive Strengths & Weaknesses
Table 91. Roche Basic Information, Manufacturing Base and Competitors
Table 92. Roche Major Business
Table 93. Roche Recombinant Human Somatropin for Injection Product and Services
Table 94. Roche Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Recent Developments/Updates
Table 96. Roche Competitive Strengths & Weaknesses
Table 97. Changchun GeneScience Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Changchun GeneScience Pharmaceutical Major Business
Table 99. Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Product and Services
Table 100. Changchun GeneScience Pharmaceutical Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Changchun GeneScience Pharmaceutical Recent Developments/Updates
Table 102. Changchun GeneScience Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Anhui Anke Biotechnology Basic Information, Manufacturing Base and Competitors
Table 104. Anhui Anke Biotechnology Major Business
Table 105. Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Product and Services
Table 106. Anhui Anke Biotechnology Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Anhui Anke Biotechnology Recent Developments/Updates
Table 108. Anhui Anke Biotechnology Competitive Strengths & Weaknesses
Table 109. Shanghai United Cell Biotechnology Basic Information, Manufacturing Base and Competitors
Table 110. Shanghai United Cell Biotechnology Major Business
Table 111. Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Product and Services
Table 112. Shanghai United Cell Biotechnology Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 114. Zhongshan Sinobioway Hygene Biomedicine Basic Information, Manufacturing Base and Competitors
Table 115. Zhongshan Sinobioway Hygene Biomedicine Major Business
Table 116. Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Product and Services
Table 117. Zhongshan Sinobioway Hygene Biomedicine Recombinant Human Somatropin for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Recombinant Human Somatropin for Injection Upstream (Raw Materials)
Table 119. Recombinant Human Somatropin for Injection Typical Customers
Table 120. Recombinant Human Somatropin for Injection Typical Distributors
LIST OF FIGURE
Figure 1. Recombinant Human Somatropin for Injection Picture
Figure 2. World Recombinant Human Somatropin for Injection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Human Somatropin for Injection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 5. World Recombinant Human Somatropin for Injection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Human Somatropin for Injection Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Human Somatropin for Injection Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 10. China Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Human Somatropin for Injection Production (2018-2029) & (K Units)
Figure 12. Recombinant Human Somatropin for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Human Somatropin for Injection Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Human Somatropin for Injection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Human Somatropin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Human Somatropin for Injection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Human Somatropin for Injection Markets in 2022
Figure 26. United States VS China: Recombinant Human Somatropin for Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Human Somatropin for Injection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Human Somatropin for Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Human Somatropin for Injection Production Market Share 2022
Figure 32. World Recombinant Human Somatropin for Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Human Somatropin for Injection Production Value Market Share by Type in 2022
Figure 34. Powder Injection
Figure 35. Aqueous Injection
Figure 36. World Recombinant Human Somatropin for Injection Production Market Share by Type (2018-2029)
Figure 37. World Recombinant Human Somatropin for Injection Production Value Market Share by Type (2018-2029)
Figure 38. World Recombinant Human Somatropin for Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Recombinant Human Somatropin for Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Recombinant Human Somatropin for Injection Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Recombinant Human Somatropin for Injection Production Market Share by Application (2018-2029)
Figure 45. World Recombinant Human Somatropin for Injection Production Value Market Share by Application (2018-2029)
Figure 46. World Recombinant Human Somatropin for Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Recombinant Human Somatropin for Injection Industry Chain
Figure 48. Recombinant Human Somatropin for Injection Procurement Model
Figure 49. Recombinant Human Somatropin for Injection Sales Model
Figure 50. Recombinant Human Somatropin for Injection Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
